Us Pharma Company Invest in India: American pharmaceutical company Eli Lilly will invest $ 1 billion in India in the next few years. A new manufacturing and quality centers will be created in Hyderabad, which will increase the availability of drugs such as obesity, diabetes, Alzheimer’s and cancer.
Us pharma company India expansion: A big news came on Monday for India’s pharma industry. The US drug company Eli Lilly is going to invest $ 1 billion (about 8,800 crore rupees) in India in the next few years. The company aims to increase manufacturing and supply capacity in India and partnership with local drug makers. According to experts, this step is not only for increasing business, but also to make India a part of the Global Manufacturing Network.
A new center will be built in Hyderabad
The company will set up a new factory and quality center in Hyderabad. Its aim is that medicines made in India should be supplied not only in the country, but worldwide. The new center will look after the company’s contract manufacturing network and will give technical expertise. New jobs for engineers, chemists, quality control and management will also be revealed here. Eli Lily said that they will soon start the recruitment process.
How important Elli Lily & Company’s investment for India?
- The new center will bring opportunities for the youth looking for work in Hyderabad and surrounding areas. New jobs and skill development opportunities will come.
- The supply of medicines for obesity, diabetes, Alzheimer’s, cancer and autoimmune diseases will be faster. The availability of medicines in the country will increase.
- This investment shows that India has now become a trusted hub of global healthcare and pharma manufacturing. This will strengthen India’s global identity.
Why is Eli Lily investing in India?
This planning of Ellie Lily is associated with global pressure and change in American policy. The US government has recently decided to impose 100% import duty on branded and patented medicines. Due to this, companies are increasing manufacturing in United States and are also investing in reliable markets like India. Apart from this, the generic pharmaceutical companies of India are also growing rapidly and Eli Lily’s popularity weight -losing drug is preparing to launch cheap options for Mounjaro. Meanwhile, Elli Lily launched this drug in India, which has increased people’s awareness towards the treatment of obesity.
Global demand for obesity medicine
Early this year Eli Lilly launched Mounjaro in India, which helps in weight loss and treatment of diabetes. Global demand of this medicine increased rapidly. Maunjaro and Novo Nordisk’s Wegovy increased understanding and popularity of the treatment of obesity. In just a few months, the sales of these two drugs doubled. Experts say that India is going to become the second largest obesity population in the world, so this drug is very important for the market.
How special Eli Lily comes to India for America and India?
This step of Eli Lily is important not only for India, but also for the business relations of America and India. The company has made India an important center in global supply and manufacturing networks. Experts believe that this investment will increase employment in pharma sector in India, intensify the availability of medicines and strengthen business cooperation and trust between the US and India.
Also read- Games sold at the age of 12, owner of $ 500 billion today! Read unheard story of Allen Musk
Also read- Trump Tarifs: Narendra Modi can meet Donald Trump in Malaysia on 26-27 October, talk will be on tariff